Healthcare · Pharmaceuticals & Biotechnology
The largest companies in the same industry by market cap. This company ranks #53 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.
| Company | Market cap (₹ Cr) | PE (TTM) | ROE | 1Y return | Div. yield | Quality | Valuation | Momentum |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 427,010 | 143.5 | 13.7% | 7.6% | — | 72 | 8 | 30 |
| Divi's Laboratories Limited | 244,125 | 83.0 | 15.3% | 57.8% | 0.33% | 70 | 4 | 51 |
| Torrent Pharmaceuticals Limited | 161,506 | 77.7 | 12.2% | 35.3% | 0.80% | 56 | 0 | 31 |
| Zydus Lifesciences Limited | 113,616 | 32.6 | 17.3% | 14.5% | 0.09% | 74 | 24 | 84 |
| Cipla Limited | 107,888 | 35.1 | 11.2% | -11.7% | 0.97% | 73 | 29 | 62 |
| Laurus Labs Limited | 106,505 | 122.0 | 17.1% | 128.4% | — | 78 | 24 | 53 |
| Mankind Pharma Limited | 102,382 | 46.9 | 11.7% | 0.9% | — | 68 | 12 | 86 |
| Dr. Reddy's Laboratories Limited | 100,411 | 150.9 | 10.9% | -3.7% | — | 62 | 33 | 71 |
| Sanofi India Limited (this stock) | 6,965 | 21.5 | 43.6% | -36.7% | 4.07% | 98 | 27 | 46 |
| Period end | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) | Basic EPS |
|---|---|---|---|---|
| Dec. 31, 2024 | 515 | 122 | 91 | ₹ |
| Sept. 30, 2024 | 524 | 113 | 82 | ₹ |
| June 30, 2024 | 464 | 92 | 103 | ₹ |
| March 31, 2024 | 732 | 188 | 137 | ₹ |
| Dec. 31, 2023 | 694 | 189 | 138 | ₹ |
| Sept. 30, 2023 | 715 | 210 | 152 | ₹ |
| June 30, 2023 | 706 | 183 | 123 | ₹ |
The detailed income statement is standalone-only: the consolidated feed carries just revenue, PBT and net profit.
Data unavailable (annual figures are only available from the NSE iXBRL feed's coverage period).
Data unavailable.
Data unavailable (only available from the NSE iXBRL feed's coverage period).
Data unavailable (only available from the NSE/BSE annual filing feeds' coverage period).
